Company profile: Celera
1.1 - Company Overview
Company description
- Provider of molecular diagnostic products and services that leverage knowledge of human variability to personalize disease management, enabling hospitals and clinical laboratories to detect, characterize, monitor, and select treatment for disease, including genotyping for infections diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Celera
Rhythmia
HQ: United States
Website
- Description: Provider of medical devices for treating cardiac arrhythmia, focusing on development of a 3D cardiac mapping system to improve catheter ablation procedures for tachy-arrhythmias, such as atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhythmia company profile →
Cardiovascular Systems
HQ: United States
Website
- Description: Provider of medical devices for treating peripheral and coronary vascular disease, focusing on plaque removal via orbital atherectomy systems (Diamondback 360 Peripheral and Coronary OAS, Stealth 360), as well as guide wires (ViperWire Advance, Shepherd) and support catheters (ViperCross), helping physicians address difficult disease states, including calcium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiovascular Systems company profile →
BioCardia
HQ: United States
Website
- Description: Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCardia company profile →
AtheroMed
HQ: United States
Website
- Description: Provider of peripheral atherectomy catheter systems to enhance treatment of below-the-knee disease; develops treatments for peripheral arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AtheroMed company profile →
Pathway Medical
HQ: United States
Website
- Description: Provider of medical devices for the treatment of arterial and vascular diseases, designing, developing, manufacturing, and marketing these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pathway Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Celera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Celera
2.2 - Growth funds investing in similar companies to Celera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Celera
4.2 - Public trading comparable groups for Celera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →